Thymogam 250 Mg Injection
Thymogam 250mg Injection is an immunosuppressive agent containing Antithymocyte Immunoglobulins (250mg). It is primarily used to prevent organ rejection in patients undergoing organ transplantation by modulating the body’s immune response to accept the new organ.
Contact us for sales assistance from our Biomedical Engineer.
Features:
-
Contains Antithymocyte Immunoglobulins (250mg)
-
Used for prophylaxis and treatment of acute rejection in transplant recipients
-
Suitable for use in both adult and pediatric patients
-
Administered in hospital settings under medical supervision
-
Supplied in ready-to-use vials
| Technical Specification |
|
|---|
- 250 mg per vial
-
Effective immunosuppression: Helps prevent rejection of transplanted organs
-
Rapid onset: Begins to act soon after administration
-
Broad immune modulation: Targets multiple immune pathways
-
Clinically proven: Widely used in transplant protocols worldwide
-
Safe for pediatric use under appropriate medical supervision
-
Reduces dependence on high-dose steroids
